Lumentum Announces Fiscal Third Quarter 2018 Results
05/02/2018
Fiscal Third Quarter Highlights
- Lumentum achieved Net Revenue of $298.8 million
- GAAP Operating margin of 8.5%; Non-GAAP Operating margin of 16.5%
- GAAP diluted Net income per share of $0.04; Non-GAAP diluted Net income per share of $0.78
Net revenue for the fiscal third quarter of 2018 was
Non-GAAP net income for the fiscal third quarter of 2018 was
The Company held
"Our strategy of investing in differentiated products and technologies, focusing on close relationships with market leading customers, and leveraging our technologies across multiple growing end markets, is working. Driven by strong customer demand and execution on capacity expansion, in the third quarter we achieved new record Lasers revenues, which increased 18% sequentially, and grew Telecom revenues by more than 11% sequentially, with notable strength in ROADMs, which were up 27% sequentially," said
Financial Overview – Fiscal Third Quarter Ended March 31, 2018 | |||||||||
GAAP Results ($ in millions) | |||||||||
Q3 |
Q2 |
Q3 |
Change | ||||||
FY 2018 |
FY 2018 |
FY 2017 |
Q/Q |
Y/Y | |||||
Net revenue |
$298.8 |
$404.6 |
$255.8 |
(26.1)% |
16.8% | ||||
Gross margin |
32.5% |
42.3% |
32.1% |
(980)bps |
40bps | ||||
Operating margin |
8.5% |
22.4% |
5.3% |
(1,390)bps |
320bps | ||||
Non-GAAP Results ($ in millions) | |||||||||
Q3 |
Q2 |
Q3 |
Change | ||||||
FY 2018 |
FY 2018 |
FY 2017 |
Q/Q |
Y/Y | |||||
Net revenue |
$298.8 |
$404.6 |
$255.8 |
(26.1)% |
16.8% | ||||
Gross margin |
36.3% |
44.9% |
34.4% |
(860)bps |
190bps | ||||
Operating margin |
16.5% |
28.3% |
12.6% |
(1,180)bps |
390bps |
Net Revenue by Segment ($ in millions) | |||||||||||
Q3 |
% of |
Q2 |
Q3 |
Change | |||||||
FY 2018 |
Net Revenue |
FY 2018 |
FY 2017 |
Q/Q |
Y/Y | ||||||
Optical Communications |
$246.3 |
82.4% |
$360.1 |
$216.1 |
(31.6)% |
14.0% | |||||
Lasers |
52.5 |
17.6% |
44.5 |
39.7 |
18.0% |
32.2% | |||||
Total |
$298.8 |
100.0% |
$404.6 |
$255.8 |
(26.1)% |
16.8% |
The tables above provide comparisons of quarterly results to prior periods, including sequential quarterly and year-over-year changes. A reconciliation between GAAP and non-GAAP measures is contained in this release under the section titled "Use of Non-GAAP Financial Measures."
Business Outlook
The Company expects the following for the fiscal fourth quarter 2018:
- Net Revenue to be in the range of
$275 million to $300 million - Non-GAAP Operating margin of 14.0% to 16.0%
- Non-GAAP diluted earnings per share of
$0.55 to $0.75
Note: Earnings per share based on approximately 65.3 million shares outstanding on a fully diluted basis
Our projection of 65.3 million shares outstanding does not include the potentially dilutive effect of the convertible notes, as we have the ability and intent to settle the face value in cash; and therefore, we use the treasury stock method for calculating the dilutive impact of the 2024 Notes. The notes will have an impact on our diluted earnings per share when the average price of our common stock exceeds the conversion price of
We have not provided reconciliations from GAAP to non-GAAP measures for our outlook. A large portion of non-GAAP adjustments, such as derivative liability adjustments, restructuring charges, stock-based compensation, litigation, acquisition related costs, non-cash income tax expense and credits, and other costs and contingencies unrelated to current and future operations are by their nature highly volatile and we have low visibility as to the range that may be incurred in the future. For example, in the fiscal second quarter of 2018, we had a credit of
Conference Call
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements include our expectations for our markets, including future product shipments and associated revenue, any anticipation or guidance as to future financial performance, including future net revenue, earnings per share, and operating margins, number of outstanding shares, our proposed acquisition of
Additional Information and Where to Find It
This press release references a proposed business combination involving
LUMENTUM AND OCLARO URGE INVESTORS AND SECURITY HOLDERS TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.
Investors and security holders will be able to obtain these materials (when they are available) and other documents filed with the
Participants in the Merger Solicitation
Each of
Contact Information
Investors:
Press:
The following financial tables are presented in accordance with GAAP, unless otherwise specified.
LUMENTUM HOLDINGS INC. | |||||||||||||||
Three Months Ended |
Nine Months Ended | ||||||||||||||
March 31, 2018 |
April 1, 2017 |
March 31, 2018 |
April 1, 2017 | ||||||||||||
Net revenue |
$ |
298.8 |
$ |
255.8 |
$ |
946.6 |
$ |
778.9 |
|||||||
Cost of sales |
201.0 |
172.0 |
607.6 |
523.0 |
|||||||||||
Amortization of acquired developed technologies |
0.8 |
1.7 |
2.4 |
5.1 |
|||||||||||
Gross profit |
97.0 |
82.1 |
336.6 |
250.8 |
|||||||||||
Operating expenses: |
|||||||||||||||
Research and development |
38.2 |
37.3 |
118.3 |
112.9 |
|||||||||||
Selling, general and administrative |
33.2 |
28.1 |
95.5 |
84.2 |
|||||||||||
Restructuring and related charges |
0.1 |
3.1 |
3.8 |
10.0 |
|||||||||||
Total operating expenses |
71.5 |
68.5 |
217.6 |
207.1 |
|||||||||||
Income from operations |
25.5 |
13.6 |
119.0 |
43.7 |
|||||||||||
Unrealized loss on derivative liabilities |
(20.7) |
(56.6) |
(8.6) |
(74.5) |
|||||||||||
Interest and other income (expense), net |
(2.1) |
(1.4) |
(8.7) |
(1.4) |
|||||||||||
Income (loss) before income taxes |
2.7 |
(44.4) |
101.7 |
(32.2) |
|||||||||||
Provision for (benefit from) income taxes |
— |
11.6 |
(112.9) |
15.4 |
|||||||||||
Net income (loss) |
2.7 |
(56.0) |
214.6 |
(47.6) |
|||||||||||
Items reconciling net income (loss) to net income (loss) attributable to common stockholders: |
|||||||||||||||
Cumulative dividends on Series A Preferred Stock |
(0.2) |
(0.2) |
(0.7) |
(0.6) |
|||||||||||
Earnings allocated to Series A Preferred Stock |
(0.1) |
— |
(4.9) |
— |
|||||||||||
Net income (loss) attributable to common stockholders |
$ |
2.4 |
$ |
(56.2) |
$ |
209.0 |
$ |
(48.2) |
|||||||
Net income (loss) per share attributable to common stockholders: |
|||||||||||||||
Basic |
$ |
0.04 |
$ |
(0.92) |
$ |
3.37 |
$ |
(0.80) |
|||||||
Diluted |
$ |
0.04 |
$ |
(0.92) |
$ |
3.31 |
$ |
(0.80) |
|||||||
Shares used in per share calculation: |
|||||||||||||||
Basic |
62.4 |
61.0 |
62.1 |
60.4 |
|||||||||||
Diluted shares attributable to common stockholders |
63.3 |
61.0 |
63.2 |
60.4 |
LUMENTUM HOLDINGS INC. | |||||||
March 31, 2018 |
July 1, 2017 | ||||||
ASSETS |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ |
176.8 |
$ |
272.9 |
|||
Short-term investments |
516.0 |
282.4 |
|||||
Accounts receivable, net |
164.7 |
166.3 |
|||||
Inventories |
144.2 |
145.2 |
|||||
Prepayments and other current assets |
63.0 |
63.5 |
|||||
Total current assets |
1,064.7 |
930.3 |
|||||
Property, plant and equipment, net |
301.8 |
273.5 |
|||||
Goodwill and intangibles, net |
19.9 |
21.5 |
|||||
Deferred income taxes, net |
128.2 |
3.9 |
|||||
Other non-current assets |
3.6 |
3.7 |
|||||
Total assets |
$ |
1,518.2 |
$ |
1,232.9 |
|||
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY |
|||||||
Current liabilities: |
|||||||
Accounts payable |
$ |
100.9 |
$ |
114.8 |
|||
Accrued payroll and related expenses |
33.2 |
27.5 |
|||||
Income taxes payable |
0.1 |
0.7 |
|||||
Accrued expenses |
36.3 |
19.3 |
|||||
Other current liabilities |
21.0 |
21.9 |
|||||
Total current liabilities |
191.5 |
184.2 |
|||||
Convertible notes |
329.9 |
317.5 |
|||||
Derivative liability |
60.2 |
51.6 |
|||||
Other non-current liabilities |
24.2 |
25.0 |
|||||
Total liabilities |
605.8 |
578.3 |
|||||
Redeemable convertible preferred stock: |
|||||||
Non-controlling interest redeemable convertible Series A Preferred Stock, $0.001 par value, 10,000,000 authorized shares; 35,805 shares issued and outstanding as of March 31, 2018 and July 1, 2017 |
35.8 |
35.8 |
|||||
Total redeemable convertible preferred stock |
35.8 |
35.8 |
|||||
Stockholders' equity: |
|||||||
Common stock, $0.001 par value, 990,000,000 authorized shares, 62,588,096 and 61,476,103 shares issued and outstanding as of March 31, 2018 and July 1, 2017, respectively |
0.1 |
0.1 |
|||||
Additional paid-in capital |
736.0 |
694.5 |
|||||
Retained earnings |
133.2 |
(83.2) |
|||||
Accumulated other comprehensive income |
7.3 |
7.4 |
|||||
Total stockholders' equity |
876.6 |
618.8 |
|||||
Total liabilities, redeemable convertible preferred stock, and stockholders' equity |
$ |
1,518.2 |
$ |
1,232.9 |
Use of Non-GAAP Financial Measures
In this press release,
Non-GAAP gross margin, non-GAAP operating margin, non-GAAP net income, and non-GAAP net income per share, Adjusted EBITDA, non-GAAP gross profit, non-GAAP operating income, non-GAAP income (loss) before income taxes and non-GAAP expenses exclude (i) workforce related charges such as severance, retention bonuses and employee relocation costs related to formal restructuring plans, (ii) costs for facilities not required for ongoing operations, and costs related to the relocation of certain equipment from these facilities and/or contract manufacturer facilities, (iii) stock-based compensation, (iv) amortization of acquired developed technologies, (v) non-cash interest expense, (vi) unrealized loss on derivative liability, (vii) warranty charges related to our vendor quality issues with expected future recoveries, (viii) release of a U.S. valuation allowance and the write down of deferred tax assets due to the 2017 "Tax Cuts and Jobs Act", and (ix) other charges comprised mainly of inventory write-downs due to cancelled programs, as well as, acquisition, integration, litigation and other costs and contingencies unrelated to current and future operations. Management does not believe that these non-GAAP items are reflective of the Company's underlying operating performance. The presentation of these and other similar items in
A quantitative reconciliation between GAAP and non-GAAP financial data with respect to historical periods is included in the supplemental financial table attached to this press release.
LUMENTUM HOLDINGS INC. | |||||||||||||||
Three Months Ended |
Nine Months Ended | ||||||||||||||
March 31, |
April 1, 2017 |
March 31, |
April 1, 2017 | ||||||||||||
Gross profit on GAAP basis |
$ |
97.0 |
$ |
82.1 |
$ |
336.6 |
$ |
250.8 |
|||||||
Stock-based compensation |
2.4 |
1.9 |
9.5 |
6.0 |
|||||||||||
Other charges related to non-recurring activities (a) |
8.3 |
2.2 |
24.5 |
12.1 |
|||||||||||
Amortization of acquired developed technologies |
0.8 |
1.7 |
2.4 |
5.1 |
|||||||||||
Gross profit on non-GAAP basis |
$ |
108.5 |
$ |
87.9 |
$ |
373.0 |
$ |
274.0 |
|||||||
Research and development on GAAP basis |
$ |
38.2 |
$ |
37.3 |
$ |
118.3 |
$ |
112.9 |
|||||||
Stock-based compensation |
(3.6) |
(3.0) |
(10.5) |
(8.8) |
|||||||||||
Other charges related to non-recurring activities |
0.4 |
(0.1) |
(1.4) |
(0.7) |
|||||||||||
Research and development on non-GAAP basis |
$ |
35.0 |
$ |
34.2 |
$ |
106.4 |
$ |
103.4 |
|||||||
Selling, general and administrative on GAAP basis |
$ |
33.2 |
$ |
28.1 |
$ |
95.5 |
$ |
84.2 |
|||||||
Stock-based compensation |
(5.0) |
(3.2) |
(15.1) |
(10.1) |
|||||||||||
Other charges related to non-recurring activities |
(4.1) |
(3.3) |
(6.4) |
(7.1) |
|||||||||||
Amortization of acquired developed technologies |
— |
(0.1) |
— |
(0.3) |
|||||||||||
Selling, general and administrative on non-GAAP basis |
$ |
24.1 |
$ |
21.5 |
$ |
74.0 |
$ |
66.7 |
|||||||
Income from operations on GAAP basis |
$ |
25.5 |
$ |
13.6 |
$ |
119.0 |
$ |
43.7 |
|||||||
Stock-based compensation |
11.0 |
8.1 |
35.1 |
24.9 |
|||||||||||
Other charges related to non-recurring activities (a) |
12.0 |
5.6 |
32.3 |
19.9 |
|||||||||||
Amortization of acquired developed technologies |
0.8 |
1.8 |
2.4 |
5.4 |
|||||||||||
Restructuring and related charges |
0.1 |
3.1 |
3.8 |
10.0 |
|||||||||||
Income from operations on non-GAAP basis |
$ |
49.4 |
$ |
32.2 |
$ |
192.6 |
$ |
103.9 |
|||||||
Interest and other (expense) income, net on GAAP basis |
$ |
(2.1) |
$ |
(1.4) |
$ |
(8.7) |
$ |
(1.4) |
|||||||
Non-cash other income (expense) |
(0.1) |
(0.1) |
(0.1) |
(0.3) |
|||||||||||
Effective interest expense on convertible notes |
4.2 |
1.0 |
12.4 |
1.0 |
|||||||||||
Interest and other (expense) income, net on non-GAAP basis |
$ |
2.0 |
$ |
(0.5) |
$ |
3.6 |
$ |
(0.7) |
|||||||
Income (loss) before income taxes on GAAP basis |
$ |
2.7 |
$ |
(44.4) |
$ |
101.7 |
$ |
(32.2) |
|||||||
Stock-based compensation |
11.0 |
8.1 |
35.1 |
24.9 |
|||||||||||
Other charges related to non-recurring activities (a) |
12.0 |
5.6 |
32.3 |
19.9 |
|||||||||||
Amortization of acquired developed technologies |
0.8 |
1.8 |
2.4 |
5.4 |
|||||||||||
Restructuring and related charges |
0.1 |
3.1 |
3.8 |
10.0 |
|||||||||||
Non-cash other income (expense) |
(0.1) |
(0.1) |
(0.1) |
(0.3) |
|||||||||||
Effective interest expense on convertible notes |
4.2 |
1.0 |
12.4 |
1.0 |
|||||||||||
Unrealized loss on derivative liabilities |
20.7 |
56.6 |
8.6 |
74.5 |
|||||||||||
Income before income taxes on non-GAAP basis |
$ |
51.4 |
$ |
31.7 |
$ |
196.2 |
$ |
103.2 |
|||||||
Provision for (benefit from) income taxes on GAAP basis |
$ |
— |
$ |
11.6 |
$ |
(112.9) |
$ |
15.4 |
|||||||
Impact of non-GAAP income tax (benefit) expense (b) |
0.8 |
(10.7) |
122.9 |
(9.6) |
|||||||||||
Provision for income taxes on non-GAAP basis |
$ |
0.8 |
$ |
0.9 |
$ |
10.0 |
$ |
5.8 |
|||||||
Net income (loss) on GAAP basis |
$ |
2.7 |
$ |
(56.0) |
$ |
214.6 |
$ |
(47.6) |
|||||||
Stock-based compensation |
11.0 |
8.1 |
35.1 |
24.9 |
|||||||||||
Other charges related to non-recurring activities (a) |
12.0 |
5.6 |
32.3 |
19.9 |
|||||||||||
Amortization of acquired developed technologies |
0.8 |
1.8 |
2.4 |
5.4 |
|||||||||||
Restructuring and related charges |
0.1 |
3.1 |
3.8 |
10.0 |
|||||||||||
Non-cash other income (expense) |
(0.1) |
(0.1) |
(0.1) |
(0.3) |
|||||||||||
Effective interest expense on convertible notes |
4.2 |
1.0 |
12.4 |
1.0 |
|||||||||||
Unrealized loss on derivative liabilities |
20.7 |
56.6 |
8.6 |
74.5 |
|||||||||||
Impact of non-GAAP income tax benefit (expense) (b) |
(0.8) |
10.7 |
(122.9) |
9.6 |
|||||||||||
Net income on non-GAAP basis |
$ |
50.6 |
$ |
30.8 |
$ |
186.2 |
$ |
97.4 |
|||||||
Net income per share on non-GAAP basis |
$ |
0.78 |
$ |
0.49 |
$ |
2.88 |
$ |
1.55 |
|||||||
Shares used in per share calculation - diluted on GAAP basis |
63.3 |
61.0 |
63.2 |
60.4 |
|||||||||||
Non-GAAP adjustment (c) |
— |
0.9 |
— |
1.0 |
|||||||||||
Effect of diluted securities from Series A Preferred Stock (d) |
1.5 |
1.5 |
1.5 |
1.5 |
|||||||||||
Shares used in per share calculation - diluted on non-GAAP basis |
64.8 |
63.4 |
64.7 |
62.9 |
(a) |
The increase during the nine months ended March 31, 2018 primarily relates to set-up costs of our Thailand facility, including costs of transferring product lines to Thailand, as well as inventory write-downs due to cancelled programs. |
(b) |
The change during the nine months ended March 31, 2018 is primarily attributable to a credit of $207.0 million related to a release of a U.S. valuation allowance, which was offset by the write down of deferred tax assets due to the 2017 "Tax Cuts and Jobs Act" reform in the amount of $83.0 million. |
(c) |
This adjustment represents weighted-average potentially dilutive securities from our stock-based benefit plans excluded from the computation of diluted net loss per share attributable to common stockholders on a GAAP basis because the effect would have been antidilutive. This adjustment amount is added for the computation of diluted net income per share on a non-GAAP basis as we had a net income on a non-GAAP basis for all periods presented. |
(d) |
For all periods presented, 1.5 million shares related to the potential conversion of the Series A Preferred Stock were added to the calculation of diluted shares available on a non-GAAP basis because their inclusion results in more dilutive earnings per share. |
LUMENTUM HOLDINGS INC. | |||||||||||||||
Three Months Ended |
Nine Months Ended | ||||||||||||||
March 31, |
April 1, 2017 |
March 31, |
April 1, 2017 | ||||||||||||
GAAP net income (loss) |
$ |
2.7 |
$ |
(56.0) |
$ |
214.6 |
$ |
(47.6) |
|||||||
Interest and other expense (income), net |
2.1 |
1.4 |
8.7 |
1.4 |
|||||||||||
Provision for (benefit from) income taxes (a) |
— |
11.6 |
(112.9) |
15.4 |
|||||||||||
Depreciation |
18.4 |
14.1 |
53.3 |
39.1 |
|||||||||||
Amortization |
0.8 |
1.8 |
2.4 |
5.4 |
|||||||||||
EBITDA |
24.0 |
(27.1) |
166.1 |
13.7 |
|||||||||||
Restructuring and related charges |
0.1 |
3.1 |
3.8 |
10.0 |
|||||||||||
Stock-based compensation |
11.0 |
8.1 |
35.1 |
24.9 |
|||||||||||
Other charges related to non-recurring activities (b) |
12.0 |
5.6 |
32.3 |
19.9 |
|||||||||||
Unrealized loss on derivative liabilities |
20.7 |
56.6 |
8.6 |
74.5 |
|||||||||||
Adjusted EBITDA |
$ |
67.8 |
$ |
46.3 |
$ |
245.9 |
$ |
143.0 |
(a) |
The change during the nine months ended March 31, 2018 is primarily attributable to a credit of $207.0 million related to a release of a U.S. valuation allowance, which was offset by the write-down of deferred tax assets due to the 2017 "Tax Cuts and Jobs Act" reform in the amount of $83.0 million. |
(b) |
The change during the nine months ended March 31, 2018 primarily relates to set-up costs of our Thailand facility, including costs of transferring product lines to Thailand, as well as inventory write-downs due to cancelled programs. |
View original content:http://www.prnewswire.com/news-releases/lumentum-announces-fiscal-third-quarter-2018-results-300641029.html
SOURCE